Gender Explanation For Dummys

Interesting OP. However the "third sex" has always been around. I dont believe in telling other people how to run their lives but there's elements of the trans movement I find deeply disturbing. I really dont think we should be allowing people that aren't old enough to vote, making permanent, life altering decisions like this for example.
There's cases of young children being given hormone blockers, that's parental abuse in my opinion.
Also Gender Dysphoria is A thing. By making this such A hot button political topic. Shouting "hateful" at anyone who questions it, we are tying the hands of medical professionals qualified to evaluate each person's individual situation. If you go to A psychiatrist with any other psychological issue they will ask questions, work through the issue. Try to find out the root of why you feel that way. In the current political climate they are risking their professional lives by doing that.

The first person officially recognized in the U.S. as non binary has now declared it all A mistake and has transitioned back.



Big Pharma has A role in this as well, I look askance when they are pushing something like this, is it for profit?

Another thing is parents pushing conversions on their *******. "Oh, little Billy likes barbies, let's chop his dick off"! I say hold on and wait, see if he grows out of it.

So my feeling is this. If the person wanting gender re-assignment is over 18 and has underwent counseling with A psychiatrist and doctor so they know the ins and outs (pun intended) of what they are going to go through then I say let them.

However it is the wild west out there, or at least it seems like it. Handing out gender surgeries to all and sundry, totally unregulated is A recipe for disaster. The suicide rate among transgenders is appalling. Some regulation would do A lot of good imo.

 
A key aspect of the gender pronoun controversy is that liberals have rendered gender to be no longer self-evident. This is why, in liberal "woke" spaces, everyone now introduces themselves with their gender pronouns -- there is no other way of knowing. The problem with codifying gender pronouns into law is that it is capricious: there is no real limit to the number of pronouns woke people are inventing, there is no mechanism in the English language to make those pronouns rational, and no one should be expected to remember all of them, at the cost of their career.

There is a fundamental difference between shouting "fire" and using pronouns.
  • Shouting "fire" is proscribed: it limits behavior in a free society, because that behavior causes obvious harm to society at large.
  • The use of gender pronouns is prescribed: it enforces behavior that otherwise causes no obvious harm to society at large.
Prescribed laws upon behavior that does not affect greater society, are capricious and the first steps toward tyranny. That is why liberals support them.
 
Actually its not a very small percentage at all.

Intersex humans are on the increase and have been for years. The total number of case per year has risen all through the Western world and Asia. Data collected shows up to 1.7% of a given population is an intersex person( born with male and female genitals to you).

There are also increasing numbers of XXY , 46 XX DSD, androgen insensitivity syndrome (AIS) Some people have neither XY nor XX chromosomes – for example, they may only have one X chromosome (XO)Turner syndrome, which is where a girl is missing an X chromosome. Just to name a few.

Just no, it is not even close to that high. Per the Intersex society it is more like 0.006 to 0.000076 of births. What you quoted was likely the realistic gay population percentage of the world, country or population, which ever you want to point to.
 
Just no, it is not even close to that high. Per the Intersex society it is more like 0.006 to 0.000076 of births. What you quoted was likely the realistic gay population percentage of the world, country or population, which ever you want to point to.

Wrong. it is that high. And no its wasn't realistic gay at all..You posted an opinion nothing based on fact! where as I used NCBI evidence and data.

Heres another extract to help you.

An increasing number of children are born with intersex variation (IV; ambiguous genitalia/hermaphrodite, pseudohermaphroditism, etc.). Evidence shows that endocrine-disrupting chemicals (EDCs) in the environment can cause reproductive variation through dysregulation of normal reproductive tissue differentiation, growth, and maturation if the fetus is exposed to EDCs during critical developmental times in utero. ******* studies support fish and reptile embryos exhibited IV and sex reversal when exposed to EDCs. Occupational studies verified higher prevalence of offspring with IV in chemically exposed workers (male and female). Chemicals associated with endocrine-disrupting ability in humans include organochlorine pesticides, poly-chlorinated biphenyls, bisphenol A, phthalates, dioxins, and furans. Intersex individuals may have concurrent physical disorders requiring lifelong medical intervention and experience gender dysphoria. An urgent need exists to determine which chemicals possess the greatest risk for IV and the mechanisms by which these chemicals are capable of interfering with normal physiological development in children.
Keywords: intersex variation, endocrine disrupting chemicals, ambiguous genitalia, ******* development, pesticides, reproductive birth defect
Go to:
Defining Intersex Variation
Intersex variation (IV) is a morphological and physiological anomaly where an individual is born with “congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical”.1 In essence, the reproductive organs differ from those typically associated as being male or female.2,3 Evidence supports the premise that at critical stages in ******* development exposure to exogenous chemicals known as endocrine-disrupting chemicals (EDCs) can disrupt reproductive organ differentiation and development in utero, leading to an IV condition.410
This study takes a closer look at the complex physiological mechanisms of ******* sex differentiation and development in utero and provides a better understanding of the vulnerability of the fetus to toxicological dysregulation by EDCs. With early surgical intervention of children presenting with IV no longer the preferred medical management practice, and with parents electing to delay surgery until development of secondary sex characteristics, the number of children with IV will increase.
Historically, the incidence and prevalence in IV have been difficult to quantify as few studies have been conducted classifying the numerous physical presentations of IV or quantifying specific IV conditions at birth. Some conditions of IV are reportable birth defects documented in the State Birth Defect Registries. Other variations from the physical norm are not defined as birth defects and therefore have not been documented as such. Current data indicate that an increasing trend in IV is being seen on a global basis. An early study by Lilford and Dear11 suggested that one in 2,000 newborns had some form of external genital ambiguity, but the study was not well supported by medical or scientific data, as best can be determined. A more recent review by the World Health Organization (WHO, 2016) found that frequency in sexual development variations were highly variable and ranged from 1:600 (Klinefelter syndrome) to 1:5,000 (congenital adrenal hyperplasia [CAH]).12 In 2004, an increasing trend was reported by Ahmed et al.13, examining genital anomalies in single births (excluding multiple births) in Scotland. Prevalence in hypospadias and other genital anomalies increased over an 8-year period of time from 4.0 per 1,000 births (1988) to 5.9 per 1,000 births (1996). Gaspari et al.14 also supported an increasing trend in the number of children born with IV. No study examined the incidence in IV as a comorbidity in deceased neonates or infants. Whether this increasing trend in IV is an artifact of recognition and documentation; expanded inclusivity of morphological variations in genitalia; improved medical treatment in neonates, leading to a reduced mortality rate; or declining incidence in early surgical intervention is difficult to determine with few studies and data to rely upon.
Go to:
Toxicological Dysregulation in ******* Genital Differentiation
Toxicological dysregulation can interfere with ******* tissue differentiation and adversely affect normal development of male and female morphological characteristics while in utero. Differentiation in male or female external genitalia in the fetus begins during the seventh week of gestation. Prior to this time, internal genital ducts derived from the mesonephros are present, but the fetus is not recognizable as male or female externally. Masculinization is initiated by testicular androgens (derived from Greek term “andro” meaning male) in the fetus, defining the androgynous external genitalia into a recognizable form or sex between 8 and 12 weeks of gestation. Dihydrotestosterone, a metabolite of testosterone, activates genes causing the male reproductive tract and external genitalia to develop.15 Abnormal hormone production, or action, can disrupt this process, resulting in incomplete masculinization.16 In the absence of the hormonal influence of dihydrotestosterone, a fetus will essentially develop into a female. External genitalia differentiation is therefore strongly hormonally dependent.
During this critical time in sex differentiation, the fetus is the most susceptible to chemicals in the environment with the capacity to disrupt the sensitive endocrine system. Exposing the fetus to EDCs, during this critical stage, can affect tissue differentiation, growth, and physiologic maturation and may also affect later development of secondary sex characteristics.1719 Incomplete or partial differentiation of genitalia can result in development of both male and female reproductive organs, making it a challenge to clearly identify an ******* as either male or female physically at the time of birth. Multiple genetic and nongenetic factors are capable of disrupting the dimorphic processes of sex determination, where developing gonads become a testis or ovary, and subsequent sex differentiation, where internal ducts and external genitalia form.20 These unintended birth variations have been identified by different terms over time (ambiguous genitalia, hermaphrodite, pseudohermaphrodite, etc.) with the currently embraced terminology IV.
A fetus exposed to gender altering chemicals can be born with a spectrum of morphologic variations. Ambiguous genitalia (atypical genitalia) resulting in IV may present as cryptorchidism (absence of one or both testes), perineal hypospadias (urethra opening is not at head of the penis), epispadias (urethra opening on the dorsum of the penis), and clitoromegaly (abnormal enlargement of the clitoris).2123 IV may also be accompanied by other medical or chromosomal disorders including Turner syndrome, Klinefelter syndrome, and CAH. Exposure to EDCs has been associated with an increased incidence of CAH, which can be life threatening, depending on the severity. Approximately 95% of CAH cases are caused by a 21-hydroxylase deficiency (21-OHD), a mutation in the gene that codes for the enzyme 21-OH. A deficiency in 21-OH can result in an interference in cortisol and aldosterone synthesis efficiency, resulting in increased androgen production and early on-set puberty.2428 The severity of CAH is dependent upon the magnitude of enzyme disruption and resultant interference in the synthesis of these hormones. A milder form of CAH (nonclassic CAH) is not life threatening, with symptoms appearing in late childhood or early adulthood. Signs of infertility, short stature, and early puberty can be indicators of adrenal function disruption. Individuals with CAH produce more androgens, resulting in early and excessive development of male characteristics in both males and females. Excessive androgen production can interfere with normal development of secondary sex characteristics in females during puberty and appropriate gender identity association later in life.29,30 Although not all CAH results in intersexuality, CAH is the most common cause of IV in females.31 Studies support even low-dose EDC exposure has the ability to impact sensitive mechanisms in physiological and biochemical processes, rather than only high-dose exposure.3235 A study by Ostby et al.36 examined low-level dicarboximide fungicide (vinclozolin) exposure with antiandrogenic effect to pregnant Long-Evans hooded rats. Male offspring developed numerous reproductive abnormalities including reduced anogenital distance and decreased ventral prostate size and weight. There was a significant increased incidence (+246%) of areolas in males at low-level exposure (3.125 mg kg−1/day−1) when compared to higher exposures (100 and 200 mg kg−1/day−1).36 This finding supports the potential for a bimodal antiandrogenic effect in certain EDCs. EDCs may also lay the groundwork for future disease (testicular cancer),37,38 and reproductive abnormalities (hypospadias, reduced anogenital distance, poor semen quality).39,40
Conditions of IV may present with a higher rate of heart defects. During the same time of genital development in the fetus, the heart continues differentiation and development. Early in the seventh week, the foramen secundum in the septum primum (precursor to interatrial septum of the embryological heart) closes and begins portioning into right and left heart chambers. The aortic and pulmonary trunks cleave during the eighth and ninth week in ******* development and the sinoatrial node (SA node or pacemaker of the heart) becomes identifiable as valve and septum morphogenesis continues.4146 The embryonic period (week 4–8) is a critical window of organogenesis where the embryo is at peak vulnerability to disruption in differentiation. Exposure to EDCs during this time can lead to major congenital anomalies including heart malformation, a potential indicator for CAH and IV.4750 Limb and craniofacial deformations are also associated with this critical window in ******* genital development.5153 Children with genital anomalies are at higher risk for early death due to various congenital malformations, particularly those affecting the cardiovascular system.54,55 Turner syndrome is one of the most common chromosomal abnormalities in humans and highly correlated with cardiovascular abnormalities.56 A study by Davenport57 found that 75% of fetuses with Turner syndrome had congenital heart disease. Congenital heart disease was also recorded in 25%–45% of females with Turner syndrome. Bicuspid aortic valve (16%) and coarctation of the aorta (11%) were identified as the most commonly expressed heart variation.57 In addition to cardiovascular diseases, individuals with Turner syndrome can manifest a wide spectrum of comorbidities including stunted growth, hearing loss, learning disabilities, renal malformations, and infertility.5860 Genital anomalies have also been associated with facial dysmorphisms, musculoskeletal abnormalities, and renal and respiratory failure.61 Psychological comorbidities associated with genital anomalies have also been documented. A study of Taiwanese women born with CAH showed a significant proportion of patients had been diagnosed with a psychiatric disorder.62 Congenital malformations of the heart are often the primary factor in ******* mortality and therefore are reported as the primary cause of death. Currently, reporting IV conditions as comorbidity (chromosomal disorders excluded) is not required in the U.S. and therefore lends to underreporting, further complexing the establishment of an accurate incidence or prevalence rate.
Go to:
EDC and Effect on Brain Chemistry
The recent high-profile gender transition of the 1976 United States Olympic men’s decathlon champion and heartthrob Bruce Jenner to the female Caitlyn Jenner has prompted considerable discussion and confusion as to what actually defines gender, or one’s gender identity. EDCs can interfere with the complex biochemical pathways of the brain and development of secondary sex characteristics, affecting normal behavioral or gender development consistent with the sex of the baby without dysregulation in tissue differentiation. This can affect brain chemistry and the way a person associates with his/her physiological sex or personifies his/her gender behaviorally.63,64 This interference can result in a gender dysphoria (previously termed gender identify disorder), or people whose gender identity differs from their biological sex at time of birth, which may explain the desire for surgical gender reassignment in some individuals. The American Psychiatric Association clarifies that, “gender nonconformity is not in itself a mental disorder. The critical element of gender dysphoria is the presence of clinically significant distress associated with the condition.65
Possibly the truest aspect or expression of ones’ sexuality may be best defined by the integration of an individual’s reproductive system assignment, or sex, and the expression of their sex through sexual/social behavior or gender identity. The sex/gender interaction is therefore a complex dance between chromosomal factors, genetic factors, brain chemistry, and expression of those factors in behavioral display (sexual behavior, romantic, or intimate preference; Fig. 1).
An external file that holds a picture, illustration, etc. Object name is ehi-10-2016-163f1.jpg




Notice: NOT GAY!!!!!!!!!!!

.
 
Last edited by a moderator:
Figure 1
The expression of gender by an individual is the result of the interaction between chromosomal factors, brain chemistry, behavior, and genetic factors.
Go to:
EDCs and IV in ******* Studies
Decades of research on animals exposed to EDCs provide a solid basis for understanding EDCs potential to interfere in human reproductive organ development. Early research by Guillette et al.66 examined abnormal gonadal development in juvenile alligator population of Lake Apopka, Florida. Results identified elevated estrogen/testosterone ratios in both male and female alligators exposed to estrogenic xenobiotic chemicals (dicofol, DDT, and DDT metabolites), from agricultural runoff and a pesticide manufacturing plant spill with embryos exhibiting sex reversal (male to female). Exposed male juvenile alligators had lower plasma testosterone concentrations when compared to unexposed juvenile alligators, while exposed female juvenile alligators had elevated polyovular follicles and polynuclear oocytes, which interfered in normal growth and development of the central and peripheral oocytes. The conclusion of the study determined that alteration in sexual development (abnormal size phalli, poorly organized seminiferous tubules) resulted in poor reproductive outcome.66 Research by Colborn and Clement67 reported poor growth, wasting, and lower rates of neonatal activity in animals exposed to elevated levels of estrogenic xenobiotics. Semenza et al.68 supported the finding of high mortality in embryos and neonates in EDC exposed juvenile alligators with dramatic decline in overall alligator population over a seven-year period.
More recent research involving fish species exposed to EDCs support the historical studies in reptiles. Intersexuality in fish has long been associated with exposure to treated sewage effluent from industries such as paper mills, containing chemicals with estrogenic capabilities.69 A study by Jobling et al.70 found a high degree of intersexuality among populations of wild roach fish exposed to treated sewage effluent containing a mixture of EDCs. Fish also had lower milt volume and sperm density. Female mosquitofish (Gambusia holbrooki) exposed to effluent from a paper mill showed masculinized secondary sex characteristics and altered reproductive behavior further supporting EDCs impact on gender misalignment.71
A study by Aravindakshan et al.72 of spottail shiner minnows in the St. Lawrence River showed evidence that immature and male spottail shiners exposed to xenoestrogens were linked to reduced male reproductive function (delayed spermatogenesis) and intersexuality. Ortiz-Zarragoitia et al.73 showed an increase in male intersex in the mullet species associated with xenoestrogenic compound exposure during a critical time in juvenile sex differentiation. The exposure to EDCs from wastewater treatment plants were found to alter male reproductive tissues of some species causing them to present with feminization or intersex conditions.7478 Atrazine, a common pesticide classified as an EDC, has been shown to affect the reproductive systems of frogs inducing gonadal abnormalities (multiple gonads and hermaphroditic conditions), via endocrine-disrupting processes.79 A study by Rey et al.80 found that neonatal caiman exposed in ovum to Atrazine altered the histoarchitecture of the testis and organization of the seminiferous tubules.
Other environmental conditions may enhance the effect of chemical exposure. Temperature-dependent sex determination exists in many reptilian species. A simultaneous exposure to EDCs and change in temperature range and/or length of exposure can alter male or female sex determination, although timing in gonadal differentiation is species dependent and highly variable.81,82 The synergistic potential of EDCs with temperature was examined in a study by Olmstead and LeBlanc.83 Pyriproxyfen was found to be more biologically active and caused bilateral gynandromorphism (sexual dimorphism) in some crustaceans as temperatures increased.83 Pyriproxyfen is an insecticide and juvenile hormone analog, which controls insect development cycles, preventing larvae from developing into adulthood and disabling them from reproducing.84 Aquatic species are highly affected due to their unique position in the food chain and aquatic exposure. Disruption in endocrine balance has also been confirmed in top predator birds (osprey, falcons, and eagles) and mammals, which prey on aquatic species. Exposure to DDT has been directly associated with population declines in predator birds due to interference with the hormone responsible for eggshell production.8587
Early 1960s’ research in the Great Lakes Basin reported reproductive failure among ranched mink fed fish with high concentrations of organochlorine compounds. ******* deaths and abnormalities were related to dioxin-like polychlorinated biphenyls (PCBs) and polychlorinated dibenzodioxins/polychlorinated dibenzofurans (PCDD/Fs).8890 A longitudinal study of Swedish otter populations spanning 30 years (1968–1999) showed an inverse relationship in PCB levels in the environment and successful pup outcome.91 Research on gray and ringed seals (Halichorerus grypus and Phoca hispida) during the same time period in the Baltic Sea found a dramatic increase in spontaneous abortions and sterility, leading to a dramatic decline in the seal population. Seals were found to have high concentrations of DDT and PCBs absorbed through ingestion of contaminated fish. Malformations of the claws and presence of adrenal cortex hyperplasia was also identified in affected seals.9294 EDCs have been shown to cause genetic defects and hormonal effect in domestic animals even at low-level concentrations. A study by Gajezcka95 examined the effects of low doses of zearalenone, a potent estrogenic mycotoxin metabolite, on estrogen receptors in the ovaries of prepubertal Beagle bitches. ******* of zearalenone during a critical developmental stage was found to lead to hyperestrogenism in prepubertal bitches.95 A study evaluating EDC leaching from dog toys by Wooten and Smith96 examined whether a subset of phthalates and bisphenol A (BPA) could leach out of dog toys and training devices (bumpers) into canine saliva. The synthetic EDCs commonly found in plastic revealed antiandrogenic activity of bumper leachates as well as estrogenic activity of both bumper and toy leachates, confirming the potential for endocrine disruption in pet dogs.96
Recent research examining the effect of EDCs on domestic dairy cattle found disruption of reproductive processes consistent with what has been exhibited in wild ******* populations. In a study by Meijer et al.97, drinking water contaminated with EDCs by sewage showed a decrease in overall milk production but an increase in the age at first calving. Sheep exposed to pastures fertilized with sewage sludge containing multiple EDC compounds showed reduced ******* testis development, testis weight, and altered hormone profiles.98 Goats exposed to EDCs during gestation (PCB 125 and PCB 153) had similar results as domestic dairy cattle exhibiting reduced ******* and delayed onset of puberty. PCB 153 exposed animals showed significantly higher damaged DNA in sperm and altered plasma luteinizing hormone (LH) and testosterone levels.99102 Reduced bone strength was also seen in wildlife and domestic cattle and was thought to occur from increased mineral content from low-level pollutant mixture exposure.103 Laboratory experiments on rodents validated the findings in the above studies. A study examining whether 4-tert-octylphenol (OP), an endocrine disruptor, interfered with the estrous cyclicity in neonatal rats provided strong evidence that it acted like estrogen in both neonatal and adult female rat.104 A study by Markey et al105 on the effects of BPA on mouse mammary glands revealed a disruption in the hypothalamic–pituitary–ovarian axis and/or misexpression of developmental genes in mice confirming the potential for endocrine disruption.
The primary purpose of domestic livestock is food production for human consumption. Many EDCs are lipophilic with the ability to bioaccumulate and biomagnify and are therefore retained in highly fatty products like dairy and meat. Human exposure to EDCs from consumption of ******* products is therefore both plausible and probable although the effect may vary widely, depending on consumption behavior, chemical concentration, and timing (critical life stages) of exposure.
Go to:
EDCs Effect on Reproductive Development in Humans
Additional research has provided evidentiary support for the association between EDCs and adverse effects on reproductive development in both men and women. Female reproductive disorders, including declining conception rates and latent menopause, have been associated with environmental chemicals capable of mimicry or blocking natural hormones.106,107 The effect EDCs may have on the female hypothalamic–pituitary–gonadal axis and regulation and initiation of the hormonal cascade that occurs during the transition from puberty to adulthood is complex at best and time dependent. The hypothalamus contains gonadotropin-releasing hormone-expressing neurons, which synthesizes gonadotrophin (GnRH) and releases the reproductive hormones from the pituitary gland, activating the gonads. Research by Bellingham et al.108 confirmed EDCs ability to disrupt the sexually dimorphic estrogen-sensitive neuropeptides that stimulate the secretion of LH and follicle-stimulating hormone, affecting neurochemistry during early sexual development.109
A fetus or ******* exposed to environmental triggers like EDCs during critical periods in development may not express biological disease or dysfunction until later in life. Effect of these chemicals are often first seen during early reproductive years when complications of fertility arise, and have also been identified as a potential factor in development of cancer later in life.110 Research by Svechnikov et al.111 supported the theory that the rapid increase in reproductive disorders and genital variations in humans over the past few decades are likely the cause of environmental or lifestyle factors rather than genetically caused mutations. EDCs, including organochlorine pesticides, polychlorinated biphenyls, BPA, phthalates, dioxins, and furans, have been found to possess strong estrogenic and antiandrogenic properties. Studies support that these same chemicals are associated with reproductive disorders in humans, as well as disorders in development and sexual differentiation in fish and alligator species.
Disruption of the endocrine system by EDCs in the environment has been confirmed through occupational studies of chemically exposed workers. In a study by Ratcliffe et al.112, workers fumigating papaya fields in Hawaii with ethylene dibromide (exposure for ±5 years) showed a statistically significant decrease in the sperm count per ejaculate and decreased sperm viability and motility. An increase in the proportion of morphologically abnormal sperm, including those with tapered heads and abnormal tails, was also found in exposed workers.112 A study by Gaspari et al.113, examining the incidence in genital malformations in French newborn male infants, found a direct association between parental pesticide exposure and abnormal male external genital development, including an increase in cryptorchidism (1.25%), hypospadias (0.97%), micropenis (0.35%), and disorders of sex development (DSD) (0.14%). In one of the worst industrial chemical accidents in history, the town of Seveso, Italy, was exposed to high levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) from a manufacturing accidental release during chemical production. The initial study of exposed children at the time of the release was inconclusive for immediate health effects other than chloracne; however, an increased incidence in spontaneous abortions among exposed women was noted.114 Particularly interesting is the change in sex ratio now being observed decades later in the children of the current generation, who were themselves children at the time of the Seveso accident. A study by Mocarelli et al.115, found that men exposed to TCDD had a higher female:male sex ratio in offspring, which persisted years after parental exposure. On a global level, this has profound implications. With the half-life of dioxins in the atmosphere of 21 days, dioxins become a factor in local, regional, and global atmospheric impact. Due to its characteristic persistence and ability to bioaccumulate in the soil (half-life, 9–15 years), exposure of humans to dioxins can come from consumption of meat (beef, pork, poultry, and fish) and dairy (milk and cheese) products as well as environmental exposure.116
While many chemicals are known as EDCs, other chemicals may not be currently identified as EDCs, but may possess similar capacity for cellular disruption. Carbon disulfide (CS2) has been found to impact the function of enzyme C21 hydroxylation (21-OH). Interference in 21-OH can cause decreased production in cortisol and aldosterone, and increased androgen production, resulting in early on-set puberty.117 The mechanism of interference may be histologic changes to the adrenal corticoid cells affecting mitochondrial or endoplasmic reticulum activity, the primary organelles for steroid production. As each step in the synthesis of steroid hormones is catalyzed by a specific enzyme, even a slight change in enzymatic activity can result in different types or proportions of hormones produced. CS2 also has the capability to inhibit CYP2B1 activity (active enzyme in the liver responsible for metabolism of xenobiotics), even at low levels. This increases the potential for hepatocellular damage from lipid peroxidation by reactive oxygen species resulting in elevated serum alanine transaminase (ALT) levels. A metabolite of CS2, carbonyl sulfide (COS), produces carbon monoxide (CO) and hydrogen sulfide (H2S) during biotransformation. H2S can inhibit cellular respiration creating oxidative stress and microsomal membrane changes, contributing to hepatic damage.118,119
Carbon tetrachloride (CCl4), a solvent and propellant, is more commonly known for its hepatotoxic and nephrotoxic capacity, but can also alter steroid hormone production pathways. Activation of CCL4 causes cellular damage to the adrenal cortex, affecting cortisol function. This results in impairment of adrenocorticoid activity by competing with steroid hormone receptor sites, reducing the number of receptor sites available for steroid hormone binding and interference in secretion.120 In response to the growing body of evidence supporting the adverse effects of EDCs on reproductive health, a group of European countries and the World Health Organization (WHO) established Human Reproductive Health and General Environment Network (HURGENT) in 2013. The HURGENT is an international surveillance system that fosters collaboration and exchange of information in reproductive health and environmental risk factors among European countries. Establishing a network for scientific data exchange among nations will advance longitudinal research in transgenerational reproductive health and the influence of environmental risk factors on reproduction, providing the ability to assess long-term trends across Europe.121
Go to:
 
Conclusion
With the increasing incidence of intersex birth variations, urgency exists to better understand how chemicals in the environment are affecting ******* development. Identifying specific chemicals that pose the greatest risk during this critical window in genital development and quantifying the level at which they are capable of asserting their influence is an ongoing challenge for scientists. Both genetic and nongenetic factors must be evaluated as both have been found to disrupt the dimorphic process of sex determination and subsequent sex differentiation.
Ambiguity or inability to classify individuals based on sex is not easily tolerated by our gender-centric society. Due to this emphasis on gender definition, a baby identified as having an intersex condition historically underwent a course of surgeries and hormone treatments.122 This early medical intervention compelled the intersex baby into a more defined male or female form physiologically, but, ignored the impact and potential confusion in gender identify or gender expression later in life with the onset of puberty.123 As reducing genital tissue is easier than building tissue, this often resulted in the medical surgical assignment of underdeveloped male genitalia to a female form only to have secondary sex characteristics expressed as male gender alignment later in life and a diagnosis of gender dysphoria. By medically assigning a defined sex to an intersex baby through surgical procedures and hormone treatments, we have missed biologically significant factors affecting human sex, gender determination, and inherent variation in the human species.124128 We have also overlooked apparent changes EDCs are making to our environment and the severe ramifications to reproductive health in both ******* and human species. The complex interaction that exists between the biological, psychological, social, and cultural factors influencing gender identity in intersex individuals necessitates medical decisions be made on a case-by-case basis.129 When possible, children with IV and their families should be connected with multidisciplinary teams that include specialists in fields such as genetic counseling, baby psychology, pediatric endocrinology, pediatric urology, gynecology, and public health to provide and coordinate the lifelong medical and social management IV children and their families need.130 We must make an active choice to protect the fetus from environmental exposure to EDCs and their adverse effects while providing support for those living with IV conditions. As the population of IV children is increasing and will continue to increase as long as we produce and use chemicals with EDC potential, so will our struggle to understand, accept, protect, and integrate people with IV into our society. Similar to accommodating and accepting children with other special needs, it is crucial that IV children receive equal treatment, inclusivity, and protection.
Go to:
Footnotes

ACADEMIC EDITOR:
Timothy Kelley, Editor in Chief


PEER REVIEW: Four peer reviewers contributed to the peer review report. Reviewers’ reports totaled 881 words, excluding any confidential comments to the academic editor.


FUNDING: Authors disclose no external funding sources.


COMPETING INTERESTS: Authors disclose no potential conflicts of interest.


Paper subject to independent expert blind peer review. All editorial decisions made by independent academic editor. Upon submission manuscript was subject to anti-plagiarism scanning. Prior to publication all authors have given signed confirmation of agreement to article publication and compliance with all applicable ethical and legal requirements, including the accuracy of author and contributor information, disclosure of competing interests and funding sources, compliance with ethical requirements relating to human and ******* study participants, and compliance with any copyright requirements of third parties. This journal is a member of the Committee on Publication Ethics (COPE).


] [PubMed] [Google Scholar]
 
Author Contributions
Conceived and designed the experiments: ALR, LMP. Analyzed the data: ALR, LMP, ST, HR, POD. Wrote the first draft of the manuscript: ALR, LMP. Contributed to the writing of the manuscript: ST, HR, POD. Agreed with manuscript results and conclusions: ALR, LMP, ST, HR, POD. Jointly developed the structure and arguments for the paper: ALR, LMP, ST, HR, POD. Made critical revisions and approved final version: ALR, LMP. All the authors reviewed and approved the final manuscript.

Go to:
REFERENCES
1. Lee PA, Houk CP, Ahmed SF, Hughes IA, Houk A, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics. 2006;118(2):e488–500. [PubMed] [Google Scholar]
2. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2013;21(3):245–91. [PubMed] [Google Scholar]
3. Intersex Society of North America (ISNA) What is Intersex? 2008. [Accessed June 1, 2016]. Available at: http://www.isna.org/faq/what_is_intersex.
4. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and development timing. Fertil Steril. 2008;90(4):911–40. [PMC free article] [PubMed] [Google Scholar]
5. Fowler PA, Bellingham M, Sinclair KD, et al. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol. 2012;355:231–9. [PubMed] [Google Scholar]
6. Earl-Gray L, Wilson VS, Stoker T, et al. Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int J Androl. 2006;29(1):96–104. [PubMed] [Google Scholar]
7. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153(9):4097–110. [PMC free article] [PubMed] [Google Scholar]
8. Hamlin HJ, Guillette LJ., Jr Birth defects in wildlife: the role of environmental contaminants as inducers of reproductive and developmental dysfunctions. Syst Biol Reprod Med. 2010;56(2):113–21. [PubMed] [Google Scholar]
9. Niemuth NJ, Klapper RD. Emerging wastewater contaminant metformin causes intersex and reduced fecundity in fish. Chemosphere. 2015;135:38–45. [PubMed] [Google Scholar]
10. Accord Alliance (n.d.). Intersex. [Accessed June 1, 2016]. Available at http://www.accordalliance.org/glossary/intersex/
11. Lilford RJ, Dear PR. The intersex baby. Br J Hosp Med (Lond) 1987;37(1):28–30. [PubMed] [Google Scholar]
12. World Health Organization (WHO) Gender and Genetics: Genetic Components of Sex and Gender. [Accessed July 27, 2015]. Available at: http://www.who.int/genomics/gender/en/index1.html.
13. Ahmed SF, Dobbie R, Finlayson AR, et al. Prevalence of hypospadias and other genital anomalies among singleton births, 1988–1997, in Scotland. Arch Dis baby ******* Neonatal Ed. 2004;89:F149–51. [PMC free article] [PubMed] [Google Scholar]
14. Gaspari L, Paris F, Jandel C, et al. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case–control study. Hum Reprod. 2011;26(11):3155–62. [PubMed] [Google Scholar]
15. Svechnikov K, Stukenborg JB, Savchuck I, Söder O. Similar causes of various reproductive disorders in early life. Asian J Androl. 2014;16:50–9. [PMC free article] [PubMed] [Google Scholar]
16. Sharpe R. Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol Lett. 2001;120:221–32. [PubMed] [Google Scholar]
17. Kavlock RJ, Daston GP, DeRosa C, et al. Research needs for the assessment of health and environmental effects of endocrine disruptor: a report of the US EPA-sponsored workshop. Environ Health Perspect. 1996;104(Suppl 4):715–40. [PMC free article] [PubMed] [Google Scholar]
18. Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity in later years. Am J Clin Nutr. 2011;94(6 Supple):1939S–42S. [PMC free article] [PubMed] [Google Scholar]
19. Acerini CL, Hughes IA. Endocrine disrupting chemicals: a new and emerging public health problem? Arch Dis baby. 2006;91:633–8. [PMC free article] [PubMed] [Google Scholar]
20. Laino L, Majore S, Preziosi N, et al. Disorders of sex development: a genetic study of patients in a multidisciplinary clinic. Endocr Connect. 2014;3(4):180–92. [PMC free article] [PubMed] [Google Scholar]
21. World Health Organization (WHO) Gender and Genetics: Genetic Components of Sex and Gender. [Accessed July 27, 2015]. Available at: http://www.who.int/genomics/gender/en/index1.html.
22. National Institute of Health (NIH) NIH FY 2016–2020 Strategic plan to advance research on the health and well-bring of sexual and gender minorities. [Accessed October 11, 2015]. Available at: http://edi.nih.gov/sites/default/files/EDI_Public_files/sgm-strategic-plan.pdf.
23. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab. 2008;22(1):119–34. [PubMed] [Google Scholar]
24. Öcal B, Berberoğlu M, Siklar Z, et al. Clinical review of 95 patients with 46, XX disorders of sex development based on the New Chicago classification. J Pediatr Adolesc Gyneco. 2015;28(1):6–11. [PubMed] [Google Scholar]
25. Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60. [PMC free article] [PubMed] [Google Scholar]
26. Frisén L, Nordenström A, Falhammar H, et al. Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21 A2 deficiency. J Clin Endocrinol Metab. 2009;94(9):3432–9. [PubMed] [Google Scholar]
27. Erdoğan S, Kara C, Uçaktürk A, Aydin M. Etiological classification and clinical assessment of children and adolescents with disorders of sex development. J Clin Res Pediatr Endocrinol. 2011;3(2):77–83. [PMC free article] [PubMed] [Google Scholar]
28. Kousta E, Papathanasiou A, Skordis N. Sex determination and disorders of sex development according to the revised nomenclature and classification in 46, XX individuals. Hormones. 2010;9(3):218–31. [PubMed] [Google Scholar]
29. Frisén L, Nordenström A, Falhammar H, et al. Gender role behaviour, sexuality, and psychosocial adaptation in women and congenital adrenal hyperplasia due to CYP21 A2 deficiency. J Clin Endocrinol Metab. 2009;94(9):3432–9. [PubMed] [Google Scholar]
30. Liang HY, Chang HL, Chen CY, Chang PY, Lo FS, Lee LW. Psychiatric manifestation in young females with congenital adrenal hyperplasia in Taiwan. Chang Gung Med J. 2008;31:66–73. [PubMed] [Google Scholar]
31. Blackless M, Charuvastra A, Derryck A, Fausto-Sterling A, Lauzanne K, Lee E. How sexually dimorphic are we? Review and synthesis. Am J Hum Biol. 2000;12:151–66. [PubMed] [Google Scholar]
32. NTP (National Toxicology Program) Endocrine Disruptors Low-Dose Peer Review. Research Triangle Park: NTP; 2003. [Accessed March, 22, 2016]. Final report of the endocrine disruptors low-dose peer review panel. Available at: http://ntp.niehs.nih.gov/ntp/htdocs/liason/lowdosepeerfinalrpt.pdf. [Google Scholar]
33. Vom Saal FS, Timms BG, Montano MM, et al. Prostate enlargement in mice due to ******* exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A. 1997;94:2056–62. [PMC free article] [PubMed] [Google Scholar]
34. Palanza P, Howdeshell KL, Parmigiani S, vom Saal FS. Exposure to a low dose of Bisphenol A during ******* life or in adulthood alters material behavior in mice. Env Health Perspect. 2002;110(Suppl 3):415–22. [PMC free article] [PubMed] [Google Scholar]
35. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology. 2012;153(9):4097–110. [PMC free article] [PubMed] [Google Scholar]
36. Ostby J, Monosson E, Kelce WR, Gray LE., Jr Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rate. Toxicol Ind Health. 1999;15:48–64. [PubMed] [Google Scholar]
37. Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology. 1996;7(1):14–9. [PubMed] [Google Scholar]
38. Wang MH, Baskin LS. Endocrine disruptors, genital development, and hypospadias. J Androl. 2008;29(5):499–505. [PubMed] [Google Scholar]
39. Newbold RR. Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity in later years. Am J Clin Nutr. 2011;94(6 supple):1939S–42S. [PMC free article] [PubMed] [Google Scholar]
40. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: opinion. Hum Reprod. 2001;16(5):972–8. [PubMed] [Google Scholar]
41. Bartman T, Hove J. Mechanics and function in heart morphogenesis. Dev Dyn. 2005;233:373–81. [PubMed] [Google Scholar]
42. Anderson RH, Webb S, Brown NA, Lamers W, Moorman A. Development of the heart: (3) formations of the ventricular outflow tracts, arterial valves and intrapericardial arterial trunks. Heart. 2003;9(9):1110–8. [PMC free article] [PubMed] [Google Scholar]
43. Costa VM, Carvalho F, Duarte JA, de Lourdes Bastos M, Remião F. The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol. 2013;26:1285–311. [PubMed] [Google Scholar]
44. Korones S. Anatomic aspects of ******* development. Glob Libr Womens Med. 2008:1–22. doi: 10.3843/GLOWM.10102. [CrossRef] [Google Scholar]
45. Rauhut-Klaban M, Bruska M, Woźniak W. Early trabeculation and close of the interventricular foramen in staged human embryos. Folia Morphol. 2008;67(1):13–8. [PubMed] [Google Scholar]
46. Anderson RH, Webb S, Brown NA, Lamers W, Moorman A. Development of the heart: (3) formations of the ventricular outflow tracts, arterial valves and intrapericardial arterial trunks. Heart. 2003;9(9):1110–8. [PMC free article] [PubMed] [Google Scholar]
47. Artamonova GV, Shapovlova EB, Maksimov SA, Skripchenko AE, Ogarkov Mlu. The environment as a risk factor for coronary heart disease in urbanized regions with developed chemical industry. Kardiologiia. 2012;52(10):86–90. [PubMed] [Google Scholar]
48. Thornton PS, Satin-Smith MS, Glaser HK, et al. Familial hyperinsulism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr. 1998;132(1):9–14. [PubMed] [Google Scholar]
49. Costa VM, Carvalho F, Duarte JA, de Lourdes Bastos M, Remião F. The heart as a target for xenobiotic toxicity: the cardiac susceptibility to oxidative stress. Chem Res Toxicol. 2013;26:1285–311. [PubMed] [Google Scholar]
50. Gorini F, Chiappi E, Gargani L, Picano E. Potential effects of environmental chemical contamination in congenital heart disease. Pediatr Cardiol. 2014;35:559–68. [PubMed] [Google Scholar]
51. Gorlin RJ, Kantaputra P, Aughton DJ, Julliken JB. Marked female predilection in some syndromes associate with facial hemangiomas. Am J Med Genet. 1994;52:130–5. [PubMed] [Google Scholar]
52. Ermito S, Dinatale A, Carrara S, Cavaliere A, Imbruglia L, Recupero S. Prenatal diagnosis of limb abnormalities: role of ******* ultrasonography. J Prenat Med. 2009;3(2):18–22. [PMC free article] [PubMed] [Google Scholar]
53. Lingaiah K, Parshwanath BA, Mysore SR, Krishnamurthy B, Ramachandra NB. A rare case of congential heart disease with ambiguous genitalia. Indian J Hum Genet. 2010;16(3):166–8. [PMC free article] [PubMed] [Google Scholar]
54. Low Y, Deshpande AV, Hutson JM. Lethal comorbidity with genital anomaly in the *******. J Pediatr Urol. 2006;2(6):534–8. [PubMed] [Google Scholar]
55. Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner Syndrome. Pediatrics. 2006;118(4):e1220–5. [PubMed] [Google Scholar]
56. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am. 1991;20:121–52. [PubMed] [Google Scholar]
57. Davenport ML. Approach to the patient with Turner Syndrome. J Clin Endocrinol Metab. 2010;95:1487–95. [PubMed] [Google Scholar]
58. Stenberg AE, Nylen O, Windh M, Hultcrantz M. Otological problems in children with Turner’s syndrome. Hear Res. 1998;124(1–2):85–90. [PubMed] [Google Scholar]
59. Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner Syndrome. Pediatrics. 2006;118(4):e1220–5. [PubMed] [Google Scholar]
60. Bolar K, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab. 2008;93(2):344–51. [PubMed] [Google Scholar]
61. Low Y, Deshpande AV, Hutson JM. Lethal comorbidity with genital anomaly in the *******. J Pediatr Urol. 2006;2(6):534–8. [PubMed] [Google Scholar]
62. Liang HY, Chang HL, Chen CY, Chang PY, Lo FS, Lee LW. Psychiatric manifestation in young females with congenital adrenal hyperplasia in Taiwan. Chang Gung Med J. 2008;31:66–73. [PubMed] [Google Scholar]
63. Fausto-Sterling A. The dynamic development of gender variability. J Homosex. 2012;59:398–421. [PubMed] [Google Scholar]
64. Laino L, Majore S, Presiosi N, et al. Disorders of sex development: a genetic study of patients in a multidisciplinary clinic. Endocr Connect. 2014;3(4):180–192. [PMC free article] [PubMed] [Google Scholar]
65. The American Psychiatric Association Gender Dysphoria. 2013. [Accessed April 13, 2016]. Available at: http://www.dsm5.org/documents/genderdysphoriafactsheet.pdf.
66. Guillette LJ, Jr, Gross TS, Masson GR, Matter JM, Percival HF, Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect. 1994;102:680–8. [PMC free article] [PubMed] [Google Scholar]
67. Colborn T, Clement C, editors. Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton, NJ: Princeton Scientific Pub. Co; 1992. [Google Scholar]
68. Semenza JC, Tolbert PE, Rubin CH, Guillette LJ, Jr, Jackson RJ. Reproductive toxins and alligator abnormalities at Lake Apopka, Florida. Environ Health Perspect. 1997;105(10):1030–2. [PMC free article] [PubMed] [Google Scholar]
69. Bortone SA, Davis WP. Fish intersexuality as indicator of environmental stress. Bioscience. 1994:165–72. [Google Scholar]
70. Jobling S, Beresford N, Nolan M, et al. Altered sexual maturation and gamete production in wild roach (Rutilus rutilus) living in rivers that receive treated sewage effluents. Biol Reprod. 2002;66(2):272–81. [PubMed] [Google Scholar]
71. Parks LG, Lambright CS, Orlando EF, Guilette LJ, Jr, Ankley GT, Gray LE., Jr Masculinization of female mosquitofish in Kraft Mill effluent-contaminated Fenholloway River water is associated with androgen receptor agonist activity. Toxicol Sci. 2001;62:257–67. [PubMed] [Google Scholar]
72. Aravindakshan J, Paquet V, Gregory M, et al. Consequences of xenoestrogen exposure on male reproductive function in spottail shiners (Notropis hudsonius) Toxicol Sci. 2004;78:156–65. [PubMed] [Google Scholar]
73. Ortiz-Zarragoitia M, Bizarro C, Rojo-Bartolomé I, de Cerio OD, Cajaraville MP, Cancio I. Mugilid fish are sentinels of exposure to endocrine disrupting compounds in coastal and estuarine environments. Mar *******. 2014;12(9):4756–82. [PMC free article] [PubMed] [Google Scholar]
74. Niemuth NJ, Klapper RD. Emerging wastewater contaminant metformin causes intersex and reduced fecundity in fish. Chemosphere. 2015;135:38–45. [PubMed] [Google Scholar]
75. Jobling S, Burn RW, Thorpe K, Williams R, Tyler C. Statistical modeling suggest that antiandrogens in effluents from wastewater treatment works contribute to widespread sexual disruption in fish living in English rivers. Environ Health Perspect. 2009;117:797–802. [PMC free article] [PubMed] [Google Scholar]
 
76. Blazer VS, Iwanowica LR, Henderson H, et al. Reproductive endocrine disruption in small mouth bass (Micropterus dolomieu) in the Potomac River base: spatial and temporal comparisons of biological effects. Environ Monit Assess. 2012;184:4309–34. [PMC free article] [PubMed] [Google Scholar]
77. Bjerregaard LB, Korsgaard B, Bjerregaard P. Intersex in wild roach (Rutilus rutilus) from Danish sewage effluent-receiving streams. Ecotoxicol Environ Saf. 2006;64:321–8. [PubMed] [Google Scholar]
78. Jobling S, Burn RW, Thorpe K, Williams R, Tyler C. Statistical modeling suggest that antiandrogens in effluents from wastewater treatment works contribute to widespread sexual disruption in fish living in English rivers. Environ Health Perspect. 2009;117:797–802. [PMC free article] [PubMed] [Google Scholar]
79. Hayes TB, Collins A, Lee M, et al. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses. Proc Natl Acad Sci U S A. 2002;99(8):5476–80. [PMC free article] [PubMed] [Google Scholar]
80. Rey F, González M, Zayas MA, et al. Prenatal exposure to pesticides disrupts testicular histoarchitecture and alters testosterone levels in male Caiman latirostris. Gen Comp Endocrinol. 2009;162(3):286–92. [PubMed] [Google Scholar]
81. Merchant-Larios H, Díaz-Hernández V. Environmental sex determination mechanisms in reptiles. Sex Dev. 2013;7:95–102. [PubMed] [Google Scholar]
82. Kohno S, Parrott BB, Yatsu R, et al. Gonadal differentiation in reptiles exhibiting environmental sex determination. Sex Dex. 2015;8:208–26. [PubMed] [Google Scholar]
83. Olmstead AW, LeBlanc GA. The environmental-endocrine basis of gynandromorphism (intersex) in a crustacean. Int J Biol Sci. 2007;3(2):77–84. [PMC free article] [PubMed] [Google Scholar]
84. Sullivan J. Environmental fate of pyriproxyfen (white paper) 2002. [Accessed July 27, 2015]. Available at: www.cdpr.ca.gov/docs/emon/pubs/fatememo/pyrprxfn.pdf.
85. Grove RA, Henny CJ, Kaiser JL. Osprey: worldwide sentinel species for assessing and monitoring environmental contamination in rivers, lakes, reservoirs and estuaries. As levels of DDE increased research showed a direct correlation to chick survival and reproductive success in predator birds. J Toxicol Environ Health B Crit Rev. 2009;12(1):25–44. [PubMed] [Google Scholar]
86. Blus LJ, Henny CJ. Field studies on pesticides and birds: unexpected and unique relations. Ecol Appl. 1997;7(4):1125–32. [Google Scholar]
87. Bouwman H, Polder A, Venter B, Skaare JU. Organochlorine contaminants in cormorant, darter, egret and ibis eggs from South Africa. Chemosphere. 2008;71(2):227–41. [PubMed] [Google Scholar]
88. Wren CD. Cause-effect linkages between chemicals and populations of mink (Mustela vison) and otter (Lutra canadensiss) in the Great Lakes Basin. J Toxicol Environ Health. 1991;33:549–85. [PubMed] [Google Scholar]
89. Brunstrom B, Lund BO, Bergman A, et al. Reproductive toxicity in mink (Mustel vison) chronically exposed to environmentally relevant polychlorinated biphenyl concentrations. Environ Toxicol Chem. 2001;20:2318–27. [PubMed] [Google Scholar]
90. Gisey JP, Verbrugge DA, Othout RA, et al. Contaminants in fish from Great Lakes-influenced sections and above dams of three Michigan rivers: II: implications for health of mink. Arch Environ Contam Toxicol. 1994;27:213–23. [PubMed] [Google Scholar]
91. Roos A, Greyerz E, Olsson M, Sandegren F. The otter (Lutra lutra) in Sweden – population trends in relation to DDT and total PCB concentrations during 1968–99. Environ Poll. 2001;111:457–69. [PubMed] [Google Scholar]
92. De Wit CA. Effects of endocrine disrupters in wild birds and mammals. In: Grotmol T, Bernhoft A, Eriksen GS, Flaten TP, editors. Endocrine Disrupters. Oslo: The Norwegian Academy of Science and Letters; 2006. [Accessed May 21, 2016]. Available at: http://www.dnva.no/binfil/download.php?tid=48846. [Google Scholar]
93. Helle E, Olsson M, Jensen S. DDT and PCB levels and reproduction in ringed seal from the Bothnian Bay. Ambio. 1976;5:188–9. [Google Scholar]
94. Olsson M, Andersson Ö, Bergman ÄÄ, Blomkvist G, Frank A, Rappe C. Contaminants and diseases in seals from Swedish waters. Ambio. 1992;21:561–2. [Google Scholar]
95. Gajezcka M. The effects of experimental administration of low doses of zearalenone on the histology of ovaries in pre-pubertal bitches. Pol J Vet Sci. 2012;15(4):685–91. [PubMed] [Google Scholar]
96. Wooten KJ, Smith PN. Canine toys and training devices as sources of exposure to phthalates and bisphenol A: quantitation of chemicals in leachate and in vitro screening for endocrine activity. Chemosphere. 2013;93:2245–53. [PubMed] [Google Scholar]
97. Meijer GAS, deBree JA, Wagenaar JA, Spoelstra SF. Sewer gas overflows put production and fertility of dairy cows at risk. J Environ Qual. 1999;28:1381–3. [Google Scholar]
98. Rhind SM. Are endocrine disrupting compounds a threat to farm ******* health. Welfare and productivity? Repro Dom Anim. 2005;40:282–90. [PubMed] [Google Scholar]
99. Hyder SM, Kirkland JL, Loose-Mitchell DS, Makela S, Stancel GM. Differential regulation of gene expression by oestrogenic ligands: a potential basis for the toxicity of environmental oestrogens. In: Naz RK, editor. Endocrine Disrupters: Effects on Male and Female Reproductive Systems. Boca Raton: CRC Press; 1999. pp. 165–86. [Google Scholar]
100. Lyche JL, Skaare JU, Larsen HJS, Ropstad E. Levels of PCB 126 and PCB 153 in plasma and tissues in goats exposed during gestation and *******. Chemosphere. 2004;55:621–9. [PubMed] [Google Scholar]
101. Lyche JL, Larsen HJS, Skaare JU, et al. Effects of perinatal exposure to low doses of PCB 153 and PCB 126 on lymphocyte proliferation and hematology in goat *******. J Toxicol Environ Health A. 2004;67:889–904. [PubMed] [Google Scholar]
102. Oskam IC, Lyche JL, Frogenaes A, et al. Effects of long-term maternal exposure to low doses of PCB126 and PCB 153 on the reproductive system and related hormones of young male goats. Reproduction. 2005;130:731–42. [PubMed] [Google Scholar]
103. Rhind SM, Evans NP, Bellingham M, et al. Effects on environmental pollutants on the reproduction and welfare of ruminants. *******. 2010;4(7):1227–39. [PMC free article] [PubMed] [Google Scholar]
104. Blake CA, Ashiru OA. Disruption of rat estrous cyclicity by the environmental estrogen 4-tert-octylphenol. Proc Soc Exp Biol Med. 1997;216(3):446–51. [PubMed] [Google Scholar]
105. Markey CM, Luque EH, Munoz de Toro M, Sonnenschein C. In utero exposure to bisphenol-A alters the development and tissue organization of the mouse mammary gland. Biol Reprod. 2001;64:1215–23. [PubMed] [Google Scholar]
106. McLachlan JA, Simpson E, Martin M. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab. 2006;20(1):63–75. [PubMed] [Google Scholar]
107. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and development timing. Fertil Steril. 2008;90(4):911–40. [PMC free article] [PubMed] [Google Scholar]
108. Bellingham M, Fowler PA, Amezaga MR, et al. ******* hypothalamic and pituitary expression of gonadotrophin-releasing hormone and galanin systems is disturbed by exposure to sewage sludge chemicals via maternal ingestion. J Neuroendocrinol. 2010;22:527–33. [PMC free article] [PubMed] [Google Scholar]
109. Fowler PA, Bellingham M, Sinclair KD, et al. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol. 2012;355:231–9. [PubMed] [Google Scholar]
110. Dickerson SM, Gore AC. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life-cycle. Rev Endocr Metab Disorder. 2007;8:143–59. [PubMed] [Google Scholar]
111. Svechnikov K, Stukenborg JB, Savchuck I, Söder O. Similar causes of various reproductive disorders in early life. Asian J Androl. 2014;16:50–9. [PMC free article] [PubMed] [Google Scholar]
112. Ratcliffe JM, Schrader SM, Steenland K, Clapp DE, Turner T, Hornung RW. Semen quality in papaya workers with long term exposure to ethylene dibromide. Br J Ind Med. 1987;44(5):317–26. [PMC free article] [PubMed] [Google Scholar]
113. Gaspari L, Paris F, Jandel C, et al. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case–control study. Hum Reprod. 2011;26(11):3155–62. [PubMed] [Google Scholar]
114. Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC. The Seveso studies on early and long-term effects of Dioxin exposure: a review. Environ Health Perspect. 1998;106(Suppl2):625–33. [PMC free article] [PubMed] [Google Scholar]
115. Mocarelli P, Gerthoux PM, Ferrari E, et al. Paternal concentration of dioxin and sex ratio of offspring. Lancet. 2000;355:1858–63. [PubMed] [Google Scholar]
116. U.S. Environmental Protection Agency Dioxins and Furans. [Accessed July 21, 2015]. Available at: http://www.epa.gov/pbt/pubs/dioxins.htm. Updated April 18, 2011.
117. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylas deficiency. Endocr Rev. 2013;21(3):245–91. [PubMed] [Google Scholar]
118. Chapin CC. Toxic Responses of the Endocrine Systems. In: Klaassen CD, editor. Casarett & Doull’s Toxicology: The Basic Science of Poisons. 6th ed. New York, NY: McGraw-Hill Companies, Inc; 2001. pp. 719–23. [Google Scholar]
119. Dalvi PS, Dalvi RR, Billups LH. Potentiation of the hepatic toxicity of carbon disulfide by chlordane. Toxico Int. 2013;20:132–7. [PMC free article] [PubMed] [Google Scholar]
120. Chapin CC. In: Casarett & Doull’s Toxicology: The Basic Science of Poisons. 6th ed. Klaassen CD, editor. New York, NY: McGraw-Hill Companies, Inc; 2001. pp. 719–23. [Google Scholar]
121. Le Moal J, Sharpe RM, Jorgensen N, et al. Toward a multi-country monitoring system of reproductive health in the context of endocrine disrupting chemical exposure. Eur J Public Health. 2016;26(1):76–83. [PubMed] [Google Scholar]
122. World Health Organization (WHO) Genomic Resource Centre Gender and Genetics. [Accessed March 21, 2016]. Available at: http://www.who.int/genomics/gender/en.
123. Allen C. It’s a boy! Gender expectations intrude on the study of sex determination. DNA Cell Biol. 2006;26(10):699–705. [PubMed] [Google Scholar]
124. Bodenhausen G. Diversity in the person, diversity in the group: challenges of identity complexity for social perception and social interaction. Eur J Soc Psychol. 2010;40:1–16. [Google Scholar]
125. Allen C. It’s a boy! Gender expectations intrude on the study of sex determination. DNA Cell Biol. 2006;26(10):699–705. [PubMed] [Google Scholar]
126. World Health Organization (WHO) Sexual and reproductive health: eliminating ******, coercive and otherwise involuntary sterilization. [Accessed February 17, 2016]. Available at: http://www.who.int/reproductivehealth/publications/gender_rights/eliminating-******-sterilization.
127. United Nations General Assembly Human Rights Council, 22nd Session: report of the Special rapporteur on ******* and other cruel, inhuman or degrading treatment or punishment. 2013. [Accessed February 10, 2016]. Available at: http://www.ohchr.org/Documents/HRBodies/HRCouncil/RegularSession/Session22/A.HRC.22.53_English.pdf.
128. Rupprecht M Childrens’ right to physical integrity Parliamentary Assembly Council of Europe Report: Committee on Social Affairs, Health and Sustainability Development Doc. 13297. 2013. [Accessed February 17, 2016]. Available at: http://assembly.coe.int/nw/xml/XRef/X2H-Xref-ViewPDF.asp?FileID=20057&lang=en.
129. Australian Parliament Second report: involuntary and ******* sterilization of intersex people in Australia. 2013. [Accessed February 06, 2016]. Available at: http://www.aph.gov.au/Parliamentary...rs/Involuntary_Sterilisation/Sec_Report/index.
130. Wiesemann C, Ude-Koeller S, Sinnecker GH, Thyen U. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. Eur J Pediatr. 2010;169(6):671–9. [PMC free article
 
Wrong. it is that high. Just yes. And no its wasn't realistic gay at all..

The stat I quoted was from the Intersex Society of North America. You know the people who actually have the genetic defect and are vested in the research and overstatement of the problem to garner public funding.

By any valid scientific measure and the broadest definition the total population for true Intersex is very small. I have seen less than 2 million. And by a huge over estimates it is less that 10 million alive world wide. or 0.1%. I mean born true Intersex. Hell the active gay population, per the gay activist grossly over estimated stats, is less than 3%. Not the bogus "Identify as gay" survey hyped by the media earlier this year.
 
The stat I quoted was from the Intersex Society of North America. You know the people who actually have the genetic defect and are vested in the research and overstatement of the problem to garner public funding.

By any valid scientific measure and the broadest definition the total population for true Intersex is very small. I have seen less than 2 million. And by a huge over estimates it is less that 10 million alive world wide. or 0.1%. I mean born true Intersex. Hell the active gay population, per the gay activist grossly over estimated stats, is less than 3%. Not the bogus "Identify as gay" survey hyped by the media earlier this year.

Sorry to burst your indignation but global research was added into the mix with the research bodies of the NCBI. Back to the gay community. Intersex isn't a gay dominated scenario as it concerns ALL unborn to birth status. Yet disturbingly you keep bringng it...
 
I'll add something into the mix for you to consider. Notice my data includeds both the US and the rest of the world. You know, the scientific community with a vested interest in research yet are not over stating it. Evry one up to the UN say the same. Yet you accuse the US of overstating the data findings. Global figures say other than what you are suggesting. The global scientific communities facts research and data do not back your opinions up. Not even your gay assumptions either are backed up by facts or research. Its that simple.
 
76. Blazer VS, Iwanowica LR, Henderson H, et al. Reproductive endocrine disruption in small mouth bass (Micropterus dolomieu) in the Potomac River base: spatial and temporal comparisons of biological effects. Environ Monit Assess. 2012;184:4309–34. [PMC free article] [PubMed] [Google Scholar]
77. Bjerregaard LB, Korsgaard B, Bjerregaard P. Intersex in wild roach (Rutilus rutilus) from Danish sewage effluent-receiving streams. Ecotoxicol Environ Saf. 2006;64:321–8. [PubMed] [Google Scholar]
78. Jobling S, Burn RW, Thorpe K, Williams R, Tyler C. Statistical modeling suggest that antiandrogens in effluents from wastewater treatment works contribute to widespread sexual disruption in fish living in English rivers. Environ Health Perspect. 2009;117:797–802. [PMC free article] [PubMed] [Google Scholar]
79. Hayes TB, Collins A, Lee M, et al. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses. Proc Natl Acad Sci U S A. 2002;99(8):5476–80. [PMC free article] [PubMed] [Google Scholar]
80. Rey F, González M, Zayas MA, et al. Prenatal exposure to pesticides disrupts testicular histoarchitecture and alters testosterone levels in male Caiman latirostris. Gen Comp Endocrinol. 2009;162(3):286–92. [PubMed] [Google Scholar]
81. Merchant-Larios H, Díaz-Hernández V. Environmental sex determination mechanisms in reptiles. Sex Dev. 2013;7:95–102. [PubMed] [Google Scholar]
82. Kohno S, Parrott BB, Yatsu R, et al. Gonadal differentiation in reptiles exhibiting environmental sex determination. Sex Dex. 2015;8:208–26. [PubMed] [Google Scholar]
83. Olmstead AW, LeBlanc GA. The environmental-endocrine basis of gynandromorphism (intersex) in a crustacean. Int J Biol Sci. 2007;3(2):77–84. [PMC free article] [PubMed] [Google Scholar]
84. Sullivan J. Environmental fate of pyriproxyfen (white paper) 2002. [Accessed July 27, 2015]. Available at: www.cdpr.ca.gov/docs/emon/pubs/fatememo/pyrprxfn.pdf.
85. Grove RA, Henny CJ, Kaiser JL. Osprey: worldwide sentinel species for assessing and monitoring environmental contamination in rivers, lakes, reservoirs and estuaries. As levels of DDE increased research showed a direct correlation to chick survival and reproductive success in predator birds. J Toxicol Environ Health B Crit Rev. 2009;12(1):25–44. [PubMed] [Google Scholar]
86. Blus LJ, Henny CJ. Field studies on pesticides and birds: unexpected and unique relations. Ecol Appl. 1997;7(4):1125–32. [Google Scholar]
87. Bouwman H, Polder A, Venter B, Skaare JU. Organochlorine contaminants in cormorant, darter, egret and ibis eggs from South Africa. Chemosphere. 2008;71(2):227–41. [PubMed] [Google Scholar]
88. Wren CD. Cause-effect linkages between chemicals and populations of mink (Mustela vison) and otter (Lutra canadensiss) in the Great Lakes Basin. J Toxicol Environ Health. 1991;33:549–85. [PubMed] [Google Scholar]
89. Brunstrom B, Lund BO, Bergman A, et al. Reproductive toxicity in mink (Mustel vison) chronically exposed to environmentally relevant polychlorinated biphenyl concentrations. Environ Toxicol Chem. 2001;20:2318–27. [PubMed] [Google Scholar]
90. Gisey JP, Verbrugge DA, Othout RA, et al. Contaminants in fish from Great Lakes-influenced sections and above dams of three Michigan rivers: II: implications for health of mink. Arch Environ Contam Toxicol. 1994;27:213–23. [PubMed] [Google Scholar]
91. Roos A, Greyerz E, Olsson M, Sandegren F. The otter (Lutra lutra) in Sweden – population trends in relation to DDT and total PCB concentrations during 1968–99. Environ Poll. 2001;111:457–69. [PubMed] [Google Scholar]
92. De Wit CA. Effects of endocrine disrupters in wild birds and mammals. In: Grotmol T, Bernhoft A, Eriksen GS, Flaten TP, editors. Endocrine Disrupters. Oslo: The Norwegian Academy of Science and Letters; 2006. [Accessed May 21, 2016]. Available at: http://www.dnva.no/binfil/download.php?tid=48846. [Google Scholar]
93. Helle E, Olsson M, Jensen S. DDT and PCB levels and reproduction in ringed seal from the Bothnian Bay. Ambio. 1976;5:188–9. [Google Scholar]
94. Olsson M, Andersson Ö, Bergman ÄÄ, Blomkvist G, Frank A, Rappe C. Contaminants and diseases in seals from Swedish waters. Ambio. 1992;21:561–2. [Google Scholar]
95. Gajezcka M. The effects of experimental administration of low doses of zearalenone on the histology of ovaries in pre-pubertal bitches. Pol J Vet Sci. 2012;15(4):685–91. [PubMed] [Google Scholar]
96. Wooten KJ, Smith PN. Canine toys and training devices as sources of exposure to phthalates and bisphenol A: quantitation of chemicals in leachate and in vitro screening for endocrine activity. Chemosphere. 2013;93:2245–53. [PubMed] [Google Scholar]
97. Meijer GAS, deBree JA, Wagenaar JA, Spoelstra SF. Sewer gas overflows put production and fertility of dairy cows at risk. J Environ Qual. 1999;28:1381–3. [Google Scholar]
98. Rhind SM. Are endocrine disrupting compounds a threat to farm ******* health. Welfare and productivity? Repro Dom Anim. 2005;40:282–90. [PubMed] [Google Scholar]
99. Hyder SM, Kirkland JL, Loose-Mitchell DS, Makela S, Stancel GM. Differential regulation of gene expression by oestrogenic ligands: a potential basis for the toxicity of environmental oestrogens. In: Naz RK, editor. Endocrine Disrupters: Effects on Male and Female Reproductive Systems. Boca Raton: CRC Press; 1999. pp. 165–86. [Google Scholar]
100. Lyche JL, Skaare JU, Larsen HJS, Ropstad E. Levels of PCB 126 and PCB 153 in plasma and tissues in goats exposed during gestation and *******. Chemosphere. 2004;55:621–9. [PubMed] [Google Scholar]
101. Lyche JL, Larsen HJS, Skaare JU, et al. Effects of perinatal exposure to low doses of PCB 153 and PCB 126 on lymphocyte proliferation and hematology in goat *******. J Toxicol Environ Health A. 2004;67:889–904. [PubMed] [Google Scholar]
102. Oskam IC, Lyche JL, Frogenaes A, et al. Effects of long-term maternal exposure to low doses of PCB126 and PCB 153 on the reproductive system and related hormones of young male goats. Reproduction. 2005;130:731–42. [PubMed] [Google Scholar]
103. Rhind SM, Evans NP, Bellingham M, et al. Effects on environmental pollutants on the reproduction and welfare of ruminants. *******. 2010;4(7):1227–39. [PMC free article] [PubMed] [Google Scholar]
104. Blake CA, Ashiru OA. Disruption of rat estrous cyclicity by the environmental estrogen 4-tert-octylphenol. Proc Soc Exp Biol Med. 1997;216(3):446–51. [PubMed] [Google Scholar]
105. Markey CM, Luque EH, Munoz de Toro M, Sonnenschein C. In utero exposure to bisphenol-A alters the development and tissue organization of the mouse mammary gland. Biol Reprod. 2001;64:1215–23. [PubMed] [Google Scholar]
106. McLachlan JA, Simpson E, Martin M. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab. 2006;20(1):63–75. [PubMed] [Google Scholar]
107. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and development timing. Fertil Steril. 2008;90(4):911–40. [PMC free article] [PubMed] [Google Scholar]
108. Bellingham M, Fowler PA, Amezaga MR, et al. ******* hypothalamic and pituitary expression of gonadotrophin-releasing hormone and galanin systems is disturbed by exposure to sewage sludge chemicals via maternal ingestion. J Neuroendocrinol. 2010;22:527–33. [PMC free article] [PubMed] [Google Scholar]
109. Fowler PA, Bellingham M, Sinclair KD, et al. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol. 2012;355:231–9. [PubMed] [Google Scholar]
110. Dickerson SM, Gore AC. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life-cycle. Rev Endocr Metab Disorder. 2007;8:143–59. [PubMed] [Google Scholar]
111. Svechnikov K, Stukenborg JB, Savchuck I, Söder O. Similar causes of various reproductive disorders in early life. Asian J Androl. 2014;16:50–9. [PMC free article] [PubMed] [Google Scholar]
112. Ratcliffe JM, Schrader SM, Steenland K, Clapp DE, Turner T, Hornung RW. Semen quality in papaya workers with long term exposure to ethylene dibromide. Br J Ind Med. 1987;44(5):317–26. [PMC free article] [PubMed] [Google Scholar]
113. Gaspari L, Paris F, Jandel C, et al. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case–control study. Hum Reprod. 2011;26(11):3155–62. [PubMed] [Google Scholar]
114. Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC. The Seveso studies on early and long-term effects of Dioxin exposure: a review. Environ Health Perspect. 1998;106(Suppl2):625–33. [PMC free article] [PubMed] [Google Scholar]
115. Mocarelli P, Gerthoux PM, Ferrari E, et al. Paternal concentration of dioxin and sex ratio of offspring. Lancet. 2000;355:1858–63. [PubMed] [Google Scholar]
116. U.S. Environmental Protection Agency Dioxins and Furans. [Accessed July 21, 2015]. Available at: http://www.epa.gov/pbt/pubs/dioxins.htm. Updated April 18, 2011.
117. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylas deficiency. Endocr Rev. 2013;21(3):245–91. [PubMed] [Google Scholar]
118. Chapin CC. Toxic Responses of the Endocrine Systems. In: Klaassen CD, editor. Casarett & Doull’s Toxicology: The Basic Science of Poisons. 6th ed. New York, NY: McGraw-Hill Companies, Inc; 2001. pp. 719–23. [Google Scholar]
119. Dalvi PS, Dalvi RR, Billups LH. Potentiation of the hepatic toxicity of carbon disulfide by chlordane. Toxico Int. 2013;20:132–7. [PMC free article] [PubMed] [Google Scholar]
120. Chapin CC. In: Casarett & Doull’s Toxicology: The Basic Science of Poisons. 6th ed. Klaassen CD, editor. New York, NY: McGraw-Hill Companies, Inc; 2001. pp. 719–23. [Google Scholar]
121. Le Moal J, Sharpe RM, Jorgensen N, et al. Toward a multi-country monitoring system of reproductive health in the context of endocrine disrupting chemical exposure. Eur J Public Health. 2016;26(1):76–83. [PubMed] [Google Scholar]
122. World Health Organization (WHO) Genomic Resource Centre Gender and Genetics. [Accessed March 21, 2016]. Available at: http://www.who.int/genomics/gender/en.
123. Allen C. It’s a boy! Gender expectations intrude on the study of sex determination. DNA Cell Biol. 2006;26(10):699–705. [PubMed] [Google Scholar]
124. Bodenhausen G. Diversity in the person, diversity in the group: challenges of identity complexity for social perception and social interaction. Eur J Soc Psychol. 2010;40:1–16. [Google Scholar]
125. Allen C. It’s a boy! Gender expectations intrude on the study of sex determination. DNA Cell Biol. 2006;26(10):699–705. [PubMed] [Google Scholar]
126. World Health Organization (WHO) Sexual and reproductive health: eliminating ******, coercive and otherwise involuntary sterilization. [Accessed February 17, 2016]. Available at: http://www.who.int/reproductivehealth/publications/gender_rights/eliminating-******-sterilization.
127. United Nations General Assembly Human Rights Council, 22nd Session: report of the Special rapporteur on ******* and other cruel, inhuman or degrading treatment or punishment. 2013. [Accessed February 10, 2016]. Available at: http://www.ohchr.org/Documents/HRBodies/HRCouncil/RegularSession/Session22/A.HRC.22.53_English.pdf.
128. Rupprecht M Childrens’ right to physical integrity Parliamentary Assembly Council of Europe Report: Committee on Social Affairs, Health and Sustainability Development Doc. 13297. 2013. [Accessed February 17, 2016]. Available at: http://assembly.coe.int/nw/xml/XRef/X2H-Xref-ViewPDF.asp?FileID=20057&lang=en.
129. Australian Parliament Second report: involuntary and ******* sterilization of intersex people in Australia. 2013. [Accessed February 06, 2016]. Available at: http://www.aph.gov.au/Parliamentary...rs/Involuntary_Sterilisation/Sec_Report/index.
130. Wiesemann C, Ude-Koeller S, Sinnecker GH, Thyen U. Ethical principles and recommendations for the medical management of differences of sex development (DSD)/intersex in children and adolescents. Eur J Pediatr. 2010;169(6):671–9. [PMC free article

I am going to give this a chance. I read this and I want you to tell me what does this report say? And where does the 1.7 % come from? The only stats in your report backs my stat.
 
I am going to give this a chance. I read this and I want you to tell me what does this report say? And where does the 1.7 % come from? The only stats in your report backs my stat.

AHAHAHA nice try. Your stats are not in the least backed up by the research. But hey keep trying.

If you have read the report then you should already have an understanding. Also IF you had read it you wouldn't still be arguing.. As I said NICE TRY!!

I'll tell you one thing. Intersex Variation is a genetic disorder NOT a gay status. You see one in two thousand children born have some kind of Intersex Variation brought on by various compounds that are previalent today its roughly the same amount of people having red hair for example.. The 1.7% is in the Office of the United Nations High Commissioner for Human Rights report.
 
Last edited by a moderator:
I quote your report- "An early study by Lilford and Dear11 suggested that one in 2,000 newborns had some form of external genital ambiguity, but the study was not well supported by medical or scientific data, as best can be determined. A more recent review by the World Health Organization (WHO, 2016) found that frequency in sexual development variations were highly variable and ranged from 1:600 (Klinefelter syndrome) to 1:5,000 (congenital adrenal hyperplasia [CAH]).12 In 2004, an increasing trend was reported by Ahmed et al.13, examining genital anomalies in single births (excluding multiple births) in Scotland. Prevalence in hypospadias and other genital anomalies increased over an 8-year period of time from 4.0 per 1,000 births (1988) to 5.9 per 1,000 births (1996). Gaspari et al.14 also supported an increasing trend in the number of children born with IV. No study examined the incidence in IV as a comorbidity in deceased neonates or infants. Whether this increasing trend in IV is an artifact of recognition and documentation; expanded inclusivity of morphological variations in genitalia; improved medical treatment in neonates, leading to a reduced mortality rate; or declining incidence in early surgical intervention is difficult to determine with few studies and data to rely upon."

Do that math and tell me the percentage of 1 in 2000, 1 in 5000, 1 in 600.

So you don't know or you didn't read it. This is an attempt to appear like a valid research study. It does make a somewhat lucid, but superficial argument that the introduction of and increase environmental base levels of some listed chemicals possibly increase the occurrence of intersex births. Primarily in the alligator and fish population. Then it goes off the rails with lots of "likely," "suggests" and "appears" statements morphing into a unsupported claim that it could be a possible, maybe a correlation to the human population. But no where did I see the level of 1.7% of world or any human population of Intersex humans quoted.

Yet this report still does not back your 1.7% and the UN on Human Rights is a political org not a valid research source. Again this BS still does not address the overall topic. It however is a febrile attempt to introduce a insignificantly small genetic deviation to cloud the issue that you can't argue. Unless you are a science denier.
 
Last edited:
If the thread is about Gender reassignment/classification, then gender pronouns is relevant to gender assignment, as most who want to be a different gender want to be addressed by different pronouns.......I think all this gender pronoun bullshit and people going to jail for it is simply wrong.

The trans argument has evolved from a biologically-based "trapped-in-the-wrong-body", to a metaphysical claim that "feeling-like-a-woman" is entirely sufficient evidence of being female. This metaphysical argument affords a great deal more political power, since feelings cannot be disputed. We are seeing the results everywhere: from locker rooms and showers to speech laws.

But the metaphysical argument has major flaws. If we trans-girls are not constrained by our biological sex -- if we are free to identify our gender as defined by our inner guidance -- then we cannot demand others acquiescence to our belief. In doing so we restrict their metaphysical freedom to identify themselves by different beliefs. Metaphysical freedom applies to all. So far however, this discrepancy has not slowed down the trans-train.

I suppose I should be happy about this; there has never been a better time to be a trans-girl. But these speech-codes and restrictions are in direct opposition to fundamental American freedoms: life, liberty and the pursuit of happiness.
 
Last edited:
Settling this, once and for ALL...

If you have a dick, you are a male. (Size does NOT matter for this explanation!)

If you DON'T have a dick, you are a female.

You can have a fantasy about whatever you want and you can identify as a Giraffe if you want to; but that doesn't change your gender!

YOU ARE WELCOME! DeeAnna & Tommi
Size does NOT matter full stop
 
Back
Top